0001209191-19-030200.txt : 20190516
0001209191-19-030200.hdr.sgml : 20190516
20190516083203
ACCESSION NUMBER: 0001209191-19-030200
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190514
FILED AS OF DATE: 20190516
DATE AS OF CHANGE: 20190516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McMahon Gerald PhD
CENTRAL INDEX KEY: 0001290747
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38800
FILM NUMBER: 19830609
MAIL ADDRESS:
STREET 1: 300 ELLIOTT AVENUE WEST
STREET 2: SUITE 500
CITY: SEATTLE
STATE: WA
ZIP: 98119-4114
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708493
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473458693
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE CT #250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-443-7400
MAIL ADDRESS:
STREET 1: 4000 SHORELINE CT #250
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-14
0
0001708493
Harpoon Therapeutics, Inc.
HARP
0001290747
McMahon Gerald PhD
C/O HARPOON THERAPEUTICS, INC.
4000 SHORELINE COURT, SUITE 250
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2019-05-14
4
P
0
1000
10.1573
A
3000
D
/s/ Gerald McMahon by Christopher Whitmore, Attorney-in-Fact
2019-05-16